|
| |
|
New Products for Protein Design and Peptidomimetics in Drug
Discovery
|
|
Fluorinated Alanine Surrogates
|
|
Catalog No.
|
Chemical Name and Description
|
Structure
|
|
BF-05-1301
|
dl-N-Boc-3,3,3-Trifluoroalanine, methyl ester
MF: C 9 H 14 F 3 NO 4 ; MW: 257.21
Package Size: 1g ; 5g ; 25g ; 100g
|

|
|
BF-05-1302
|
dl-3,3,3-Trifluoroalanine, methyl ester, HCl Salt
MF: C 4 H 7 ClF 3 NO 2 ; MW: 193.55; CAS NO: [27240-44-4]
Package Size: 1g ; 5g ; 25g ; 100g
|

|
|
BF-05-1303
|
dl-3,3,3-Trifluoroalanine, HCl Salt
MF: C 3 H 5 F 3 NO 2 Cl; MW: 179.53
Package Size: 1g ; 5g ; 25g ; 100g
|

|
|
BF-05-1304
|
dl-3,3,3-Trifluoroalanine (Free Base)
MF: C 3 H 4 F 3 NO 2 ; MW: 143.06; CAS NO: [
17463-43-3 ]
Package Size: 1g ; 5g ; 25g ; 100g
|

|
| Fluorinated
Valine Surrogates |
|
BF-05-1305
|
dl-4,4,4, 4 ′ , 4 ′ , 4 ′ -
Hexafluorovaline
MF: C 5 H 5 Cl F 6 NO 2 ; MW: 225.09 CAS NO: [
16063-80-2 ]
Package Size: 1g ; 5g
|

|
|
BF-05-1306
|
dl- Methyl-4,4,4, 4 ′ , 4 ′ , 4 ′ -
Hexafluorovalinate, HCI Salt
MF: C 6 H 8 F 6 NO 2 Cl; MW: 275.58;
Package Size: 1g ; 5g
|

|
|
BF-05-1307
|
dl-4,4,4,4 ′ , 4 ′ , 4 ′ -
Hexafluorovaline, t -buty1 ester, HCI Salt
MF: C 9 H 14 F 6 NO 2 Cl; MW: 317.66
Package Size: 1g ; 5g
|

|
|
BF-05-1308
|
(s)-N-Boc-4,4,4,4 ′ , 4 ′ , 4 ′ -
Hexafluorovaline
MF: C 10 H 13 F 6 NO 4 ; MW: 325.20
Package Size: 1g ; 5g
|

|
|
BF-05-1309
|
(s)-N-Fmoc-4,4,4,4 ′ , 4 ′ , 4 ′ -
Hexafluorovaline
MF: C 20 H 15 F 6 NO 4 ; MW: 447.33
Package Size: 1g ; 5g
|

|
|
New Products for Protein Design and Peptidomimetics in Drug
Discovery
|
|
Fluorinated Leucine Surrogates
|
|
Catalog No.
|
Chemical Name and Description
|
Structure
|
|
BF-05-1310
|
dl-5,5,5,5 ′ , 5 ′ , 5 ′
-Hexafluoroleucine, (Free base)
MF: C 6 H 7 F 6 NO 2 ; MW: 275.58; CAS NO:
[16198-60-0]
Package Size: 1g ; 5g
|

|
|
BF-05-1311
|
(s)-5,5,5,5 ′ , 5 ′ , 5 ′
-Hexafluoroleucine, HCI Salt
MF: C 6 H 7 F 6 NO 2 HCl; MW: 275.58
Package Size: 1g ; 5g
|

|
|
BF-05-1312
|
(s)- Methy1-5,5,5,5 ′ , 5 ′ , 5 ′
-Hexafluoroleucinate, HCl Salt
MF: C 6 H 9 F 6 NO 2 HCl; MW: 289.6
Package Size: 1g ; 5g
|

|
|
BF-05-1313
|
(s)-N-Boc-5,5,5,5 ′ , 5 ′ , 5 ′
-Hexafluoroleucine
MF: C 11 H 15 F 6 NO 4 ; MW: 339.23
Package Size: 1g ; 5g
|

|
|
BF-05-1314
|
(s)-N-Fmoc-5,5,5,5 ′ , 5 ′ , 5 ′
-Hexafluoroleucine
MF: C 21 H 17 F 6 NO 4 ; MW: 461.35
Package Size: 1g ; 5g
|

|
| Other Fluorine Compounds |
|
Catalog No.
|
Chemical Name and Description
|
Structure
|
|
BF-06-1315
|
1,1,1,3,3,3-Hexafluoroisopropand
MF: C 3 H 2 F 6 O ; MW: 168.04 ; CAS NO: [ 920-66-1 ]
Package Size: 1g ; 5g
|

|
|
BF-06-1316
|
tert-butyl carbamate
MF: C 5 H 11 NO 2 ; MW: 117.15 ; CAS NO: [4248-19-5]
Package Size: 1g ; 5g
|

|
|
BF-06-1317
|
6,6,6-Trifluoronorleucine
MF: C
6 H 10 F 3 N O 2 ; MW: 185.15; CAS NO: [12 0200-04-6 ]
Package Size: 1g ; 5g
|

|
|
BF-06-1318
|
DL-2-(Trifluoromethyl)norvaline
MF: C 6 H 10 F 3 NO 2 ; MW: 185.14
Package Size: 1g ; 5g
|

|
|
BF-06-1319
|
methyl 2-acetamido-3,3,3-trifluoro-2-hydroxypropanoate
MF : C 6 H 8 F 3 NO 4
; MW :
215.13
|

|
|
BF-06-1320
|
methyl 2-acetamido-3,3,3-trifluoropropanoate
MF : C 6 H 6 F 3 NO 3
; MW :
197.11
|

|
|
BF-06-1321
|
DL-2-(Trifluoromethyl)norleucine
MF: C 7 H 12 F 3 NO 2 ; MW: 199.17
Package Size: 1g ; 5g
|

|
|
BF-06-1322
|
DL-2-(Trifluoromethyl)leucine
MF: C 7 H 12 F 3 NO 2 ; MW: 199.17
Package Size: 1g ; 5g
|

|
|
BF-06-1323
|
Methyl
5,5,5-trifluoro-2-oxo-4-(trifluoromethyl)pent-3-enoate
MF : C 7 H 4 F 6 O 3
; MW : 250.1
|

|
|
BF-06-1324
|
benzyl carbamate
MF : C 8 H 9 NO 2
; MW : 151.16
CAS NO : 621-84-1
|

|
|
BF-06-1325
|
methyl
-2-(tert-butoxycarbonyl)-3,3,3-trifluoro-2-hydroxypropanoate
MF: C 9 H 14 F 3 NO 5 ; MW: 273.21
Package Size: 1g ; 5g
|

|
|
BF-06-1326
|
methyl-2-[tert-butoxycarbonylimino]-3,3,3-trifluoropropionate
MF: C 9 H 12 F 3 NO 4 ; MW: 255.19
Package Size: 1g ; 5g
|

|
|
BF-06-1327
|
tert-butyl 4,4,4-trifluoro-3-(trifluoromethyl)but-2-enoate
MF: C 9 H 10 F 6 O 2 ; MW: 264.16
Package Size: 1g ; 5g
|

|
|
BF-06-1328
|
1,1,1,3,3,3-Hexafluoroisopropyl -4-toluensesulfonate
MF: C 10 H 8 F 6 O 3 S ; MW: 322.22 ; CAS NO: [
67674-48-0 ]
Package Size: 1g ; 5g
|

|
|
BF-06-1329
|
4-methoxy-N-(perfluoropropan-2-ylidene)benzenamine
MF : C 10 H 7 F 6 NO
; MW :
271.16
|

|
|
BF-06-1330
|
N-(3,4,5-trifluorobenzylidene)-4-methoxybenzenamine
MF : C 14 H 10 F 3NO
; MW :
265.23
|

|
|
BF-06-1331
|
4-methoxy-N-(perfluorobenzylidene)benzenamine
MF : C 14 H 8 F 5 NO
; MW :
301.21
|

|
|
BF-06-1332
|
R-(+)-N-benzy-1-phenylethylamine
MF: C 15 H 17 N ; MW: 211.3 ; CAS NO: [ 38235-77-7 ]
Package Size: 1g ; 5g
|

|
|
BF-06-1333
|
triphenyl ethyl phosphonium bromide
MF : C 20 H 20 BrP
MW : 371.25
|

|
|
BF-06-1334
|
(triphenylphosphoranylidene) ethane
MF : C 20 H 19 P
MW : 290.34
|

|
|
BF-06-1335
|
Benzyl
4,4,4-trifluoro-2-(1-phenylethylamino)-3-(trifluoromethyl)butanoate
MF : C 20 H 19 F 6 NO 2
; MW :
419.36
|

|
|
BF-06-1336
|
triphenyl methoxycarbonyl carbonyl methyl phosphonium
bromide
MF : C 22 H 20 BrO 3 P
MW : 443.27
|

|
|
BF-06-1337
|
(triphenylphosphoranylidene) methyl pyruvate
MF : C 22 H 19 O 3 P
MW : 362.36
|

|
|
BF-06-1338
|
triphenyl
tert butoxycarbonyl methyl phosphonium bromide
MF : C 24 H 26 BrO 2 P
MW : 457.34
|

|
|
BF-06-1339
|
(triphenylphosphoranylidene) tert-butyl acetate
MF : C 24 H 25 O 2 P
MW : 376.43
|

|
|
BF-06-1340
|
triphenyl benzoxycarbonyl methyl phosphonium bromide
MF : C 27 H 24 BrO 2 P
MW : 491.36
|

|
|
Epitope Tag Peptide
|
|
Product Name
|
Catalog No.
|
Sequence (>97%)
|
Quantities
|
|
Flag
|
B-04-1201-1
|
DYKDDDDK
|
50 mg
|
|
B-04-1201-2
|
100mg
|
|
c-myc
|
B-04-1202-1
|
EQKLISEEDL
|
50 mg
|
|
B-04-1202-2
|
100mg
|
|
3X Flag
|
B-04-1203-1
|
MDYKDHDGDYKDHDIDYKDDDDK
|
50 mg
|
|
B-04-1203-2
|
100mg
|
|
ECS
|
B-04-1204-1
|
DDDDK
|
50 mg
|
|
B-04-1204-2
|
100mg
|
|
AU1
|
B-04-1205-1
|
DTYRYI
|
50 mg
|
|
B-04-1205-2
|
100mg
|
|
AU5
|
B-04-1206-1
|
TDFYLK
|
50 mg
|
|
B-04-1206-2
|
100mg
|
|
Glu-Glu
|
B-04-1207-1
|
EYMPME
|
50 mg
|
|
B-04-1207-2
|
100mg
|
|
HA
|
B-04-1208-1
|
YPYDVPDYA
|
50 mg
|
|
B-04-1208-2
|
100mg
|
|
T7
|
B-04-1209-1
|
MASMTGGQQMG
|
50 mg
|
|
B-04-1209-2
|
100mg
|
|
V5
|
B-04-1210-1
|
CGKPIPNPLLGLTST
|
50 mg
|
|
B-04-1210-2
|
100mg
|
|
VSV-G
|
B-04-1211-1
|
YTDIEMNRLGK
|
50 mg
|
|
B-04-1211-2
|
100mg
|
|
6-His
|
B-04-1212-1
|
HHHHHH
|
50 mg
|
|
B-04-1212-2
|
100mg
|
or
send us your request by
filling the below form.
| |
|
NEWS
|
HHC is pleased to announce that a specific youtube page is now
available. This page will be implemented in the next months and
furnished with short movies presenting our products and relevant
scientific news.
|
HHC in association with Nucleon Ltd is taking part to the 20th UICC
World Cancer Congress from 27 to 31 Auust 2008 in Geneva. Through our
presence (stand n°1116) we will promote the advantages and benefits of
using
Cytoactiv the first prognostic marker for cervical dysplasia.
 |
|